Acelyrin (SLRN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

SLRN Acelyrin

Watchlist

2.570
-0.010-0.39%

Close Feb 25 16:00 ET

2.510
-0.060-2.33%

Post 20:01 ET

257.84MMarket Cap-0.97P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Key Deals This Week: Howard Hughes, Shift4 Payments, Herc Holdings, Celsius and More
Seeking AlphaFeb 22 15:35 ET
Acelyrin (SLRN) Stock Surges After Unsolicited Buyout Proposal
Stocks TelegraphFeb 21 11:04 ET
Acelyrin Stock Jumps on Concentra Acquisition Interest
WSJFeb 21 09:16 ET
Reported Earlier, ACELYRIN Confirms Unsolicited $3/Share Offer From Concentra Biosciences Amid Pending Alumis Merger
BenzingaFeb 21 01:18 ET
Express News | ACELYRIN Confirms Receipt of Unsolicited Indication of Interest From Concentra Biosciences
ReutersFeb 20 21:01 ET
Express News | Tang Capital Management Reports 5.3% Stake in ACELYRIN as of 18TH Feb- SEC Filing
ReutersFeb 20 18:28 ET

Comments

Daight

Feb 21 08:23

$Acelyrin (SLRN.US)$
share buyback at $3, shorts only touched this a tiny bit. I think shorts would only touch this once it got over $3.

Jaguar8

Feb 20 21:50

🟤Watchlist, FEBRUARY 21,2025, Friday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...

Jaguar8

Feb 20 20:01

NEWS

$Alumis (ALMS.US)$ $Acelyrin (SLRN.US)$
ACELYRIN Confirms Receipt of Unsolicited Indication of Interest from Concentra Biosciences
Thursday, 20th February at 9:00 pm
LOS ANGELES, Feb. 20, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (NASDAQ: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today confirmed receipt of an unsolicited indication of interest from Concentra Biosciences, LLC, of which Tang Capital...

Lnova

Feb 17 20:41

T. Rowe Price Investment Management 12,851,050 shares, 12.8%
$Acelyrin (SLRN.US)$
has options
nfa

Acelyrin | SCHEDULE 13G/A: Others

SLRN Acelyrin

Trade Overview

Capital Trend

News

Comments

Trending Stocks